Group One Trading’s AC Immune ACIU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$495K Sell
180,100
-18,900
-9% -$58.7K ﹤0.01% 3357
2025
Q4
$625K Buy
+199,000
New +$628K ﹤0.01% 3290
2025
Q3
Sell
-400
Closed -$812 8305
2025
Q2
$812 Sell
400
-41,800
-99% -$72.7K ﹤0.01% 7600
2025
Q1
$78.9K Buy
42,200
+22,200
+111% +$55.9K ﹤0.01% 4786
2024
Q4
$54K Sell
20,000
-20,800
-51% -$65K ﹤0.01% 4999
2024
Q3
$154K Sell
40,800
-1,800
-4% -$6.29K ﹤0.01% 3848
2024
Q2
$170K Buy
+42,600
New +$141K ﹤0.01% 3539
2024
Q1
Sell
-1,500
Closed -$7.5K 6926
2023
Q4
$7.5K Sell
1,500
-8,700
-85% -$28K ﹤0.01% 6340
2023
Q3
$29.1K Sell
10,200
-26,000
-72% -$79.1K ﹤0.01% 5573
2023
Q2
$107K Buy
36,200
+34,000
+1,545% +$74.2K ﹤0.01% 4552
2023
Q1
$5.15K Hold
2,200
﹤0.01% 6267
2022
Q4
$4.49K Sell
2,200
-600
-21% -$1.55K ﹤0.01% 6382
2022
Q3
$9K Sell
2,800
-9,800
-78% -$30.9K ﹤0.01% 6535
2022
Q2
$45K Buy
12,600
+8,400
+200% +$28.7K ﹤0.01% 5649
2022
Q1
$17K Sell
4,200
-13,700
-77% -$59.3K ﹤0.01% 6848
2021
Q4
$89K Sell
17,900
-5,600
-24% -$32.5K ﹤0.01% 5826
2021
Q3
$158K Buy
23,500
+18,400
+361% +$132K ﹤0.01% 5420
2021
Q2
$40K Sell
5,100
-45,900
-90% -$317K ﹤0.01% 6749
2021
Q1
$388K Buy
51,000
+21,000
+70% +$150K ﹤0.01% 4330
2020
Q4
$155K Buy
+30,000
New +$153K ﹤0.01% 4247

Other funds holding ACIU

Group One Trading's ACIU Position: Q4 2024 in Review

Group One Trading sold out of AC Immune (ACIU) in Q4 2024, closing a stake of 24,074 shares — an estimated $75.2K sold.

Group One Trading first reported a position in ACIU in Q2 2021 and held it in 6 quarters. The position peaked at $91K in Q3 2024. 45 funds tracked by Wall St. Rank hold ACIU as of Q4 2024.

  • Group One Trading reported no remaining AC Immune position as of Q4 2024 after selling out during the quarter.
  • Group One Trading sold 24,074 AC Immune shares in Q4 2024, an estimated $75.2K.
  • Group One Trading first reported a position in AC Immune in Q2 2021 and held it in 6 quarters.
  • Group One Trading's AC Immune position peaked at $91K in Q3 2024.
  • 45 funds tracked by Wall St. Rank held AC Immune as of Q4 2024.

Based on Group One Trading's 13F filing for Q4 2024, filed 14 Feb 2025.